CML28 Is a Broadly Immunogenic Antigen, Which Is Overexpressed in Tumor Cells

Donor lymphocyte infusion (DLI) reliably induces durable remission in 75–80% of patients with relapsed chronic myelogenous leukemia (CML) after allogeneic hematopoietic stem cell transplantation. To identify immunological targets of the graft-versus-leukemia response (GVL) after DLI, we used CML pos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Yang, Xiao-Feng, Wu, Catherine J., Chen, Linyun, Alyea, Edwin P., Canning, Christine, Kantoff, Philip, Soiffer, Robert J., Dranoff, Glenn, Ritz, Jerome
Formato: Artigo
Idioma:Inglês
Publicado em: 2002
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4762257/
https://ncbi.nlm.nih.gov/pubmed/12359762
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados